z-logo
open-access-imgOpen Access
The Breast Cancer Susceptibility Gene BRCA1 Is Required for Subnuclear Assembly of Rad51 and Survival following Treatment with the DNA Cross-linking Agent Cisplatin
Author(s) -
Anamitra Bhattacharyya,
Uy Ear,
Beverly H. Koller,
Ralph R. Weichselbaum,
Douglas K. Bishop
Publication year - 2000
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/7d45-4d53
Subject(s) - rad51 , cisplatin , breast cancer , dna , cancer research , oncology , medicine , dna repair , cancer , biology , genetics , chemotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom